Supplementation with L-2-oxothiazolidine-4-carboxylic acid, a cysteine precursor, does not protect against lipid peroxidation in puromycin aminonucleoside-induced nephropathy

Experimental Nephrology

Volumn 4, Issue 4, 1996, Pages 248-252

  Fawcett, J P ^a   Schiller, B ^c   Jiang, R ^a   Moran, J ^d   Walker, R J ^b  

^a UNIVERSITY OF OTAGO   (New Zealand)

^b UNIVERSITY OF OTAGO   (New Zealand)

^c RUSH UNIVERSITY MEDICAL CENTER   (United States)

^d BAXTER HEALTHCARE CORPORATION   (United States)

Author keywords

Focal glomerulosclerosis; Glutathione; Lipid peroxidation; Procysteine; Puromycin aminonucleoside

Indexed keywords

2 OXO 4 THIAZOLIDINECARBOXYLIC ACID; DRINKING WATER; GLUTATHIONE; PUROMYCIN AMINONUCLEOSIDE;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG MECHANISM; FOCAL GLOMERULOSCLEROSIS; GLOMERULOPATHY; INTRAPERITONEAL DRUG ADMINISTRATION; LIPID PEROXIDATION; MALE; NEPHROTOXICITY; NONHUMAN; PRIORITY JOURNAL; PROTEINURIA; RAT;

ADMINISTRATION, ORAL; ANALYSIS OF VARIANCE; ANIMALS; GLOMERULOSCLEROSIS, FOCAL SEGMENTAL; GLUTATHIONE; KIDNEY CORTEX; LIPID PEROXIDATION; MALE; PUROMYCIN AMINONUCLEOSIDE; PYRROLIDONECARBOXYLIC ACID; RATS; RATS, SPRAGUE-DAWLEY; THIAZOLES; THIAZOLIDINES; THIOBARBITURIC ACID REACTIVE SUBSTANCES;

EID: 0029744314     PISSN: 10187782     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Lannigan R, Kark R, Pollak VE: The effect of a single intravenous injection of aminonucleoside of puromycin on the rat kidney. A light and electron microscope study. J Pathol Bacteriol 1962;83:357-362.
2. Diamond JR, Bonventre JV, Karnovsky MJ: A role for oxygen free radicals in aminonucleoside nephrosis. Kidney Int 1986;29:478-483.
3. Fawcett JP, Jiang R, Walker RJ: Time course of lipid peroxidation in puromycin aminonucleoside-induced nephropathy. Res Commun Mol Pathol Pharmacol 1994;86:227-234.
4. Pedraza-Chaverri J, Arévalo AE: Tissue lipoperoxidation and glutathione peroxidase activity in puromycin aminonucleoside injected rats. Int J Biochem 1994;26:1139-1145.
5. Ichikawa I, Kiyama S, Yashioka T: Renal antioxidant enzymes: Their regulation and function. Kidney Int 1994;45:1-9.
6. Ricardo SD, Bertram JE, Ryan GB: Antioxidants protect podocyte foot processes in puromycin aminonucleoside-treated rats. J Am Soc Nephrol 1994;4:1974-1986.
7. Thakur V, Walker PD, Shah SV: Evidence suggesting a role for hydroxyl radical in puromycin aminonucleoside-induced proteinuria. Kidney Int 1988;34:494-499.
8. 558 are produced by glomerular cells in passive Heymann nephritis. Proc Natl Acad Sci USA 1993;90:3645-3649.
9. Kawamura T, Yoshioka T, Bills T, Fogo A, Ichikawa I: Glucocorticoid activates glomerular antioxidant enzymes and protects glomeruli from oxidant injury. Kidney Int 1991;40:291-301.
10. Ponticelli C, Passerini P: Treatment of the nephrotic syndrome associated with primary glomerulonephritis. Kidney Int 1994;46:595-604.
11. Anderson ME, Meister A: Intracellular delivery of cysteine. Methods Enzymol 1987;143:313-325.
12. Meister A: Glutathione deficiency produced by inhibition of its synthesis and its reversal: Applications in research and therapy. Pharmacol Ther 1991;51:155-194.
13. Porta P, Aebi S, Summer K, Lauterburg BH: L-2-Oxothiazolidine-4-carboxylic acid, a cysteine prodrug: Pharmacokinetics and effects on thiols in plasma and lymphocytes in human. J Pharmacol Exp Ther 1991;257:331-334.
14. Taylor CG, Bauman PF, Sikorski B, Bray TM: Elevation of lung glutathione by oral supplementation of L-2-oxothiazolidine-4-carboxylate protects against oxygen toxicity in protein-energy malnourished rats. FASEB J 1992;6:3201-3107.
15. Williamson JM, Boettcher B, Meister A: Intracellular cysteine delivery system that protects against toxicity by promoting glutathione synthesis. Proc Natl Acad Sci USA 1982;79:6246-6249.
16. Ohkawa H, Ohishi N, Yagi K: Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 1979;95:351-358.
17. Cotgreave IA, Moldeus P: Methodologies for the application of monobromobimane to the simultaneous analysis of soluble and protein thiol components of biological systems. J Biochem Biophys Methods 1986;13:231-249.
18. McLean IW, Nakane PK: Periodate-lysine-paraformaldehyde fixative: A new fixative for immunoelectron microscopy. J Histochem Cytochem 1974;22:1077-1083.
19. Schiller B, Walker RJ, Fawcett JP, DeLeo M, Piscopo D, Moran J: MCP-1 expression accelerates FGS in experimental glomerulosclerosis: Part of a vicious circle in progressive renal disease (abstract). J Am Soc Nephrol 1994;5:768.
20. Gerard-Monnier D, Fougeat S, Gourvest JF, Chaudiere J: Partial prevention of glutathione depletion in rats following acute intoxication with diethylmaleate. Clin Physiol Biochem 1993;10:36-42.
21. Williamson JM, Meister A: Stimulation of hepatic glutathione formation by administration of L-2-oxothiazolidine-4-carboxylate, a 5-oxo-L-prolinase substrate. Proc Natl Acad Sci USA 1981;78:936-939.
22. Banks MF, Stipanuk MH: The utilisation of N-acetylcysteine and 2-oxothiazolidine-4-carboxylate by rat hepatocytes is limited by their rate of uptake and conversion to cysteine. J Nutr 1994;124:378-387.
23. Searle AJF, Willson RL: Stimulation of microsomal lipid peroxidation by iron and cysteine. Biochem J 1983;212:549-554.
24. Rush GF, Smith JH, Newton JF, Hook JB: Chemically induced nephrotoxicity: Role of metabolic activation. CRC Crit Rev Toxicol 1986;13:99-160.